clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Rare Variants Can Strongly Affect Menopause and Cancer Risk
Molecular Dx
Wearable Sensor Allows Accurate Eye Tracking to Predict Brain Disorders
News & Features
Tomosynthesis More Effective than Mammography for Breast Cancer Screening
Molecular Dx
Some Men with Prostate Cancer Can Benefit from Immunotherapy
News & Features
Brain Metastases of HER2-Positive Breast Cancer Patients Effectively Treated with Antibody-Drug…
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Epigenetic Screening Predicts Pancreatic Cancer Prognosis and Treatment Sensitivity
Prognosis
News & Features
Epigenetic Screening Predicts Pancreatic Cancer Prognosis and Treatment Sensitivity
May 24, 2021
0
Molecular Dx
New Liquid Biopsy Method IDs Melanoma Patients Likely to Relapse
February 4, 2020
0
News & Features
Residual Cancer Burden (RCB) Predicts Breast Cancer Survival
December 13, 2019
0
Molecular Dx
Mining the Microbiome: Microbiome startups are proliferating, exploring new markets, and colonizing diverse therapeutic niches
Julianna LeMieux, PhD
July 16, 2019
0
Molecular Dx
Predictive Biomarker of Metastatic Prostate Cancer Discovered
May 9, 2019
0
Molecular Dx
Thermo Fisher, NX Prenatal to Develop NIPT Proteomics Assays
April 17, 2019
0
News & Features
Glioblastoma Sex Differences Uncovered
Julianna LeMieux, PhD
April 4, 2019
0
News & Features
Consortium Seeks Regulatory Qualification of Biomarkers for Knee OA
August 2, 2018
0
Molecular Dx
Traumatic Brain Injury Biomarker Could Aid Outcome Prognosis
July 16, 2018
0
Molecular Dx
Wave to Use Deep Genomics’ AI Platform in Drug Discovery Collaboration
April 10, 2018
0
1
...
6
7
8
Page 7 of 8
Related Content
Rare Variants Can Strongly Affect Menopause and Cancer Risk
Brain Metastases of HER2-Positive Breast Cancer Patients Effectively Treated with Antibody-Drug Conjugate
New Therapy Shows Promise in Targeting Tau Tangles in Alzheimer’s Disease
Five Features Underlie Immunotherapy Response
Inside Precision Medicine
![The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a project designed to seek regulatory qualification of new biomarkers that predict the change in joint damage over time from osteoarthritis (OA) in the knee. [Source: American Academy of Orthopaedic Surgeons]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1817.jpeg "Consortium Seeks Regulatory Qualification of Biomarkers for Knee OA")
